Colgate-Palmolive (CL) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Colgate-Palmolive Company (CL) PT Raised to $115 at TD Cowen
July 29, 2024 1:10 PM EDTTD Cowen analyst Robert Moskow raised the price target on Colgate-Palmolive Company (NYSE: CL) to $115.00 (from $110.00) while maintaining a Buy rating.
The analyst comments "Colgate delivered a high quality 2Q and raised guidance meaningfully. Consistent with our positive thesis, volume growth continued to... More
Colgate-Palmolive Company (CL) PT Raised to $101 at Jefferies
July 29, 2024 6:06 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Colgate-Palmolive Company (NYSE: CL) to $101.00 (from $95.00) while maintaining a Hold rating.
The analyst comments "Colgate had to deliver a perfect qtr to sustain its 27x NTM P/E multiple. They did. Brand reinvestments are working,... More
Colgate-Palmolive Company (CL) PT Raised to $112 at Evercore ISI
July 29, 2024 5:34 AM EDTEvercore ISI analyst Robert Ottenstein raised the price target on Colgate-Palmolive Company (NYSE: CL) to $112.00 (from $106.00) while maintaining a Outperform rating.
The analyst comments "Friday, Colgates shares closed at a 30% premium to Staples, 5 points above its 20-year trading range. We do not expect CL to regress... More
Stifel on Colgate-Palmolive Company (CL): 'Lifting Estimates on Solid 2Q with Volume, EBIT Outperformance'
July 26, 2024 2:20 PM EDTStifel analyst Mark Astrachan reiterated a Buy rating and $105.00 price target on Colgate-Palmolive Company (NYSE: CL).
The analyst comments "We lift 2024-2025 EPS estimates and maintain our Buy rating and $105 price target, 17x 2025E EBITDA, following strong 2Q24 results with sales and... More
